Atezolizumab Plus Bevacizumab Alone or Combined With External Beam Radiotherapy for HCC With Macrovascular Invasion

Conditions:   Hepatocellular Carcinoma;   Hepatocellular Cancer;   Hepatocellular Carcinoma Non-resectable;   Hepatocellular Carcinoma Stage IV;   Liver Cancer Interventions:   Radiation: Atezolizumab plus bevacizumab, combined EBRT to vascular invasion;   Drug: Atezolizumab plus bevacizumab Sponsors:   Asan Medical Center;   Seoul National University Hospital;   Hanyang University;   Soon Chun Hyang University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials